Logo do repositório
 

Nasal mucociliary clearance in subjects with COPD after smoking cessation

dc.contributor.authorIto, Juliana T. [UNESP]
dc.contributor.authorRamos, Dionei [UNESP]
dc.contributor.authorLima, Fabiano F. [UNESP]
dc.contributor.authorRodrigues, Fernanda M. M. [UNESP]
dc.contributor.authorGomes, Paulo R.
dc.contributor.authorMoreira, Graciane L.
dc.contributor.authorMacchione, Mariangela
dc.contributor.authorToledo, Alessandra C.
dc.contributor.authorRamos, Ercy M. C. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionClin Med Specialties
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2015-10-21T20:51:33Z
dc.date.available2015-10-21T20:51:33Z
dc.date.issued2015-03-01
dc.description.abstractBACKGROUND: Exposure to cigarette smoke causes significant impairment in mucociliary clearance (MCC), which predisposes patients to secretion retention and recurrent airway infections that play a role in exacerbations of COPD. To determine whether smoking cessation may influence MCC and frequency of exacerbations, the following groups were evaluated: ex-smokers with COPD, smokers with COPD, current smokers with normal lung function, and nonsmokers with normal lung function. METHODS: Ninety-three subjects were divided into 4 groups: ex-smokers with COPD (n = 23, 62.4 +/- 8.0 y, 13 males), smokers with COPD (n = 17, 58.2 +/- 8.0 y, 6 males), current smokers (n = 27, 61.5 +/- 6.4 y, 17 males), and nonsmokers (n = 26, 60.8 +/- 11.3 y, 7 males). MCC was evaluated using the saccharin transit time (STT) test, and the frequency of exacerbations in the last year was assessed by questionnaire. The Kruskal-Wallis test followed by Dunn's test were used to compare STT among groups, and the Goodman test was used to compare the frequency of exacerbations. RESULTS: STT of smokers with COPD (16.5 [11-28] min; median [interquartile range 25-75%]) and current smokers (15.9 110-271 min) was longer compared with ex-smokers with COPD (9.7 [6-12] min) and nonsmokers (8 [6-16] min) (P < .001). There was no difference in STT values between smokers with COPD and current smokers, and these values in ex-smokers with COPD were similar to the control group (P > .05). The frequency of exacerbations was lower in ex-smokers with COPD compared with smokers with COPD. CONCLUSIONS: One year after smoking cessation, subjects with COPD had improved mucociliary clearance.en
dc.description.affiliationUniv Estadual Paulista UNESP, Dept Physiotherapy, Presidente Prudente, Brazil
dc.description.affiliationClin Med Specialties, Ctr Clin, Presidente Prudente, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Paulista Sch Med, Dept Med Pneumol, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, SP, Brazil
dc.description.affiliationUnespUniv Estadual Paulista UNESP, Dept Physiotherapy, Presidente Prudente, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipPrograma Institucional da Pro-Reitoria de Extensao-Universidade Estadual Paulista
dc.format.extent399-405
dc.identifierhttp://rc.rcjournal.com/content/60/3/399
dc.identifier.citationRespiratory Care. Irving: Daedalus Enterprises Inc, v. 60, n. 3, p. 399-405, 2015.
dc.identifier.doi10.4187/respcare.03266
dc.identifier.issn0020-1324
dc.identifier.lattes1470583417166740
dc.identifier.urihttp://hdl.handle.net/11449/129331
dc.identifier.wosWOS:000350898700013
dc.language.isoeng
dc.publisherDaedalus Enterprises Inc
dc.relation.ispartofRespiratory Care
dc.relation.ispartofjcr2.073
dc.relation.ispartofsjr0,971
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectChronic obstructive pulmonary diseaseen
dc.subjectSmokingen
dc.subjectMucociliary clearanceen
dc.subjectDisease exacerbationen
dc.subjectSmoking cessationen
dc.subjectRespiratory infectionsen
dc.titleNasal mucociliary clearance in subjects with COPD after smoking cessationen
dc.typeArtigo
dcterms.rightsHolderDaedalus Enterprises Inc
dspace.entity.typePublication
unesp.author.lattes1470583417166740
unesp.author.orcid0000-0002-3310-7336[9]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências e Tecnologia, Presidente Prudentept
unesp.departmentFisioterapia - FCTpt

Arquivos